Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) and remains a major global public health concern. As per Mira Hleyhe et al. (2024), approximately 50 million individuals were chronically infected globally, with 0.2 million deaths in 2022. According to the Hepatitis C epidemiology forecast by Expert Market Research, prevalence trends continue to shape global disease burden.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Hepatitis C – Number of Cases by Year

Read more about this report - Request a Free Sample

Hepatitis C Epidemiology Forecast Report Coverage

Expert Market Research's “Hepatitis C Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of hepatitis C. It projects the future incidence and prevalence rates of hepatitis C cases across various populations. The study covers age, gender, and type as major determinants of the hepatitis C population. The report highlights patterns in the prevalence of hepatitis C over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hepatitis C in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Hepatitis C Understanding: Disease Overview

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), primarily transmitted through exposure to infected blood. The infection can be acute or progress to chronic hepatitis C when the virus persists in the body. Chronic infection may cause progressive liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma if left untreated. Transmission commonly occurs through unsafe injections, sharing contaminated needles, and inadequately screened blood products. The disease is classified into different HCV genotypes, with genotypes 1–6 being the major groups, although their distribution varies geographically.

Key Report Insights

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Region

India

High-Risk Population

People who inject drugs, individuals exposed to unsafe medical procedures, and populations with higher HCV prevalence

Key Diagnostic Method

HCV antibody testing followed by HCV RNA testing for confirmation of active infection

Major Risk Factor

Exposure to HCV-contaminated blood, particularly through injection drug use and unsafe injections

Major gap in the market

Underdiagnosis and limited linkage to confirmatory testing and curative treatment

Hepatitis C Epidemiology Perspective

The hepatitis C epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the hepatitis C epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hepatitis C and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to Mira Hleyhe et al., 2024, approximately 50 million people were chronically infected with hepatitis C globally, with 0.2 million deaths in 2022. The estimated global prevalence was approximately 1%, while India was estimated at around 1%.

Gender-Specific Cases of the Disease

As per the European Centre for Disease Prevention and Control, 2023, hepatitis C was reported more frequently among men than women in the EU/EEA, with a male-to-female ratio of 1.7:1, indicating a higher reported burden among males.

Age-Specific Cases of the Disease

According to the Centers for Disease Control and Prevention, 2023, persons aged 30–39 years had the highest reported rates of acute hepatitis C in the United States. In Japan, approximately 50% of patients were over 75 years old.

Ethnicity-Wise Cases of the Disease

According to the Centers for Disease Control and Prevention, 2023, the reported acute hepatitis C rate among non-Hispanic American Indian/Alaska Native persons was 2.3 times that of non-Hispanic White persons, representing the highest rate among reported racial and ethnic groups.

Mortality and Survival Analysis of the Disease

According to Mira Hleyhe et al., 2024, hepatitis C was associated with approximately 0.2 million deaths globally in 2022. In the United States, the Centers for Disease Control and Prevention, 2023 reported 11,194 hepatitis C-related deaths during 2023.

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence

Genotype 1

Genotype 1 is the most common HCV genotype worldwide and in the United States, with common subtypes including 1a and 1b.

Genotype 2

Genotype 2 is found globally, with common subtypes including 2a, 2b, and 2c.

Genotype 3

Genotype 3 is the second most common HCV genotype globally and is highly prevalent in South Asia; genotype 3a is a common subtype.

Others

Other HCV genotypes have more geographically concentrated distributions, including genotypes 4, 5, 6, 7, and 8.

Hepatitis C – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise Hepatitis C Epidemiology

The hepatitis C epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to the Centers for Disease Control and Prevention, 2023, 4,966 new acute hepatitis C cases and 101,525 newly reported chronic hepatitis C cases were recorded. The estimated number of acute HCV infections was 69,000, and the acute hepatitis C rate was 1.5 cases per 100,000 population. Persons aged 30–39 years had the highest rates. The American Liver Foundation reports that approximately 2.7 million people in the United States have chronic hepatitis C infection.

Germany

The epidemiological burden of hepatitis C in Germany can be considered within the broader European context. According to the European Centre for Disease Prevention and Control, 2023, hepatitis C surveillance across 29 EU/EEA countries recorded 28,622 cases, corresponding to a crude rate of 7.4 cases per 100,000 population.

France

Hepatitis C epidemiology in France forms part of the broader EU/EEA surveillance landscape. As per the European Centre for Disease Prevention and Control, 2023, reported hepatitis C cases across 29 EU/EEA countries showed a male-to-female ratio of 1.7:1, with 35–44 years representing the most affected age group.

Italy

Italy contributes to the broader European hepatitis C epidemiological burden. According to the European Centre for Disease Prevention and Control, 2023, there were 28,622 hepatitis C cases reported across 29 EU/EEA countries, with 4.9% classified as acute and 34.1% as chronic.

Spain

The epidemiological profile of hepatitis C in Spain can be considered within the EU/EEA surveillance context. According to the European Centre for Disease Prevention and Control, 2023, hepatitis C was more frequently reported among men, with a male-to-female ratio of 1.7:1 across the monitored EU/EEA population.

United Kingdom

Hepatitis C epidemiology in the United Kingdom is considered within the European regional context provided. According to Mira Hleyhe et al., 2024, approximately 50 million people globally were living with chronic HCV infection, while the global prevalence of hepatitis C was approximately 1%.

Japan

According to Yuri Komaki et al., 2022, approximately 50% of patients with hepatitis C virus infection in Japan were over 75 years old, highlighting a substantial concentration of the identified patient population among older adults.

India

As per R. Ingle et al., 2023, the prevalence of hepatitis C infection in India was estimated at approximately 1%. The study reported an overall seroprevalence of 1.8%, while the cited World Health Organization estimate placed India's prevalence at around 1%.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

A major epidemiological gap in hepatitis C remains the identification of undiagnosed infections and timely linkage to curative treatment across the United States, European countries, Japan, and India. Expanded screening among populations with previous blood exposure, people who inject drugs, and other higher-risk groups can improve case detection. Integration of HCV antibody and reflex RNA testing into routine healthcare pathways may reduce diagnostic delays. Emerging opportunities include decentralized testing, simplified treatment pathways, and improved surveillance systems. Strengthening screening-to-treatment programs can support progress toward hepatitis C elimination by identifying infections earlier and increasing access to effective antiviral therapy.

Hepatitis C: Treatment Overview

Hepatitis C is now considered a curable viral infection in most patients with appropriate treatment. The primary treatment approach is oral direct-acting antiviral (DAA) therapy, which targets specific proteins required for HCV replication. Common regimens include combinations containing sofosbuvir, velpatasvir, glecaprevir, or pibrentasvir, with treatment selection based on clinical factors and previous treatment history. Therapy generally lasts 8–12 weeks and can achieve high sustained virologic response rates. Effective antiviral therapy reduces the risk of cirrhosis, liver failure, and hepatocellular carcinoma associated with chronic HCV infection.

Key Questions Answered

  • What is the current and projected burden of hepatitis C across the 8 major markets?
  • Which countries across the 8 major markets account for the highest hepatitis C patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of hepatitis C across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of hepatitis C across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of hepatitis C across the 8 major markets?
  • How do major comorbidities and risk factors influence hepatitis C epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of hepatitis C across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the hepatitis C landscape across the 8 major markets?
  • Which therapeutic areas linked to hepatitis C are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the hepatitis C epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on hepatitis C epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for hepatitis C across the 8 major markets?

Scope of the Hepatitis C Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hepatitis C based on several factors.
  • Hepatitis C Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The hepatitis C report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Antiviral Drugs Market

Liver Cirrhosis Pipeline Analysis

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us